摘要:
DNA plasmid expression vector, pCMX, enables cDNA expression cloning in mammalian cell culture. This novel expression vector exhibits a marked increase in gene expression when compared to its parental plasmid construction.
摘要:
Mice, tissues, cells, and genetic material are provided that comprise a humanized heavy chain immunoglobulin locus, a humanized light chain locus that expresses a universal light chain, and a gene encoding an ADAM6 or ortholog or homolog or functional fragment thereof. Mice are provided that express humanized heavy chains comprising human variable domains, and that express humanized light chains comprising human variable domains wherein the light chains are derived from no more than one, or no more than two, light chain V and J or rearranged V/J sequences. Fertile male mice that express antibodies with universal light chains and humanized heavy chains are provided. Methods and compositions for making bispecific binding proteins are provided.
摘要:
A genetically modified mouse is provided, wherein the mouse expresses an immunoglobulin light chain repertoire characterized by a limited number of light chain variable domains. Mice are provided that express just one or a few immunoglobulin light chain variable domains from a limited repertoire in their germline. Methods for making light chain variable regions in mice, including human light chain variable regions, are provided. Methods for making human variable regions suitable for use in multispecific binding proteins, e.g., bispecific antibodies, are provided.
摘要:
Methods of creating mutations in genomic exons by inserting introns into the genomic exons via homologous recombination. Also, methods are provided for introducing modifications into genomic exons by inserting introns into the genomic exons via homologous recombination such that a mature mRNA transcript produced from a genomic region of the genome comprising the genomic exon does not contain the modification are provided. The methods provide for a rapid method for introducing mutations and/or modifications of any type into a mammalian cell genome.
摘要:
The systems and methods disclosed herein relate to digital data communication systems, and more particularly, the systems and methods relate to systems and methods for facilitating digital communication between a modem equipped meter and a central data acquisition system. In one example, the system has the central data acquisition system, a first telemetry device that utilizes a modem for data communication, and a second telemetry device with a processor for communicating with the first telemetry device, and a digital cellular radio for communicating with the processor. The processor relays digital meter data from the first telemetry device to the digital cellular radio and the digital cellular radio transmits the digital meter data to the central data acquisition system. This system allows the utility company to transmit the reading of utility consumption by a consumer without the use of telephone lines.
摘要:
Modified chimeric polypeptides with improved pharmacokinetics are disclosed. Specifically, modified chimeric Flt1 receptor polypeptides that have been modified in such a way as to improve their pharmacokinetic profile are disclosed. Also disclosed are methods of making and using the modified polypeptides including but not limited to using the modified polypeptides to decrease or inhibit plasma leakage and/or vascular permeability in a mammal.
摘要:
The present invention provides for an isolated nucleic acid molecule encoding a human TIE-2 ligand. In addition, the invention provides for a receptorbody which specifically binds a human TIE-2 ligand. The invention also provides an antibody which specifically binds a human TIE-2 ligand. The invention further provides for an antagonist of human TIE-2. The invention further provides for a ligandbody which specifically binds TIE-2 receptor. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization, a method of promoting the growth, differentiation or migration of cells expressing the TIE-2 receptor, including, but not limited to, hematopoietic precursor cells, a method of blocking the growth, differentiation or migration of cells expressing the TIE-2 receptor including, but not limited to, hematopoietic precursor cells, and a method of attenuating or preventing tumor growth in a human.
摘要:
The invention provides antibody heavy chain constant regions with a hinge region modified to reduce binding to Fcγ receptors. The modification occurs within positions 233-236 by replacement of natural residues by glycine(s) and/or deletion(s). Such modifications can reduce binding of an antibody bearing such a constant region to Fcγ receptors to background levels. The constant regions can be incorporated into any format of antibody or Fc fusion protein. Such antibodies or fusion proteins can be used in methods of treatment, particularly those in which the mechanisms of action of the antibody or Fc fusion protein is not primarily or at all dependent on effector functions, as is the case when an antibody inhibits a receptor-ligand interaction or agonizes a receptor.
摘要:
Methods of creating mutations in genomic exons by inserting introns into the genomic exons via homologous recombination. Also, methods are provided for introducing modifications into genomic exons by inserting introns into the genomic exons via homologous recombination such that a mature mRNA transcript produced from a genomic region of the genome comprising the genomic exon does not contain the modification are provided. The methods provide for a rapid method for introducing mutations and/or modifications of any type into a mammalian cell genome.
摘要:
In one embodiment, after establishing a packet data connection (1XRTT or GPRS) and obtaining an IP address, the remote data device registers with the proxy server using UDP packets. The remote data device periodically transmits UDP packets to the proxy server to maintain the registration and possibly any NAT/firewall translations (for the UDP session) in the cellular network. The proxy server is configured to listen on a different TCP port for the remote data device. This is a fixed port number for any given remote data device and is used for addressing the remote data device by the central data acquisition system that wants to access the remote data device. When the proxy server receives a TCP connection (from the central data acquisition system) on the port for a specific remote data device, the proxy server marks the remote data device as being busy and transmits a UDP message to the remote data device informing it that a connection is requested. If the proxy server does not receive a TCP connection from the remote data device, the proxy server transmits connection no-acknowledge message to the central data acquisition system, and marks the remote data device as being idle. Upon receipt of the connection request message, the remote data device establishes a TCP session with the proxy server. The proxy server establishes communication between the central data acquisition system and the remote data device. If the proxy server can establish communication, the proxy server terminates communication and marks the remote data device as being idle.